The HIVE community supports Canadian dermatologists, allergists, immunologists and others with an interest in urticaria

Home
About HIVE
The Buzz
Whiteboard
Contact

Protected: Updates from the 30th EADV Congress: Dr. Charles Lynde reviews guidance on how to recognize unmet needs of patients with CSU and translate key clinical trial evidence into practice (Video 10 min)

March 4, 2022June 19, 2022 ~ hivecanada

This content is password-protected. To view it, please enter the password below.

Password:

‹ PreviousThe Buzz, Issue #10 is now out! This issue features randomized studies for monoclonal antibodies in CSU, a look at how Canadian parents view oral food challenge, Canadians use of topical cannabinoids, and a scoping review for identifying drug culprits for adverse cutaneous drug reactions.

Next ›Updates from the 30th EADV Congress: Dr. Ya Sophia Xu reviews guidance on selecting antihistamines for up-dosing patients with CSU, factors predicting response to treatment, and the impact of inducible urticarias in chronic urticaria [Video 12 min]

Not a HIVE member?
Sign up here

The Health Innovation Virtual Engagement (HIVE) is a cross-specialty learning community for Canadian physicians, to support collaboration and enhance understanding of the condition of urticaria.

Some content on this site is password protected, available to HIVE members. You can find the password in your weekly Sosido HIVE email digest, sent every Wednesday.

Search for:

Website Powered by WordPress.com.

Subscribe Subscribed
- The HIVE Community
- Already have a WordPress.com account? Log in now.

Related